Analytical Data
-
Gene name
A1BG/Alpha-1B-Glycoprotein
- Application
-
Species
Rat
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9EPH1
-
Expression Region
Trp22~Thr219
-
Molecular Weight
34kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Alpha-1B-glycoprotein (A1BG) is a plasma protein that plays a crucial role in various physiological processes, including immune response and inflammation regulation. Research has linked A1BG to several pathological conditions, such as cancer progression and cardiovascular diseases, making it a potential biomarker and therapeutic target. Recombinant A1BG protein offers a powerful tool for elucidating the protein’s biological functions and mechanisms of action. By generating A1BG in a controlled laboratory setting, researchers can study its interactions with other molecules and assess its role in cellular pathways. Furthermore, recombinant A1BG can be employed in the development of diagnostic assays and therapeutic interventions, providing insights that could lead to novel treatment strategies. Additionally, understanding how A1BG modulates immune responses could enhance our comprehension of autoimmune diseases and improve patient outcomes. As a result, the study of recombinant A1BG protein underscores its significance in biomedical research and holds promise for advancing our knowledge of related diseases.
